Loading company details...
Beta
Latest Form 4 (Jul 28, 2026): Sara Kenkare-Mitra (Director): Grant/Award of 47,941 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 28, 2026 | Sara Kenkare-Mitra | Grant/Award | 47,941 | n/a |
| Jul 28, 2026 | Sandeep Laumas | Grant/Award | 47,941 | n/a |
| Jun 15, 2026 | Pramod Gupta, EVP, Pharmaceuticals and BD | Grant/Award | 169,500 | n/a |
| Jun 15, 2026 | Douglas Jermasek, EVP, Corporate Strategy | Grant/Award | 169,500 | n/a |
| May 21, 2026 | Shalabh K. Gupta, CEO | Grant/Award | 762,200 | n/a |
| May 20, 2026 | John Townsend, CFO | Grant/Award | 169,500 | n/a |
| Aug 26, 2025 | Gaurav Aggarwal | Conversion | 652,900 | n/a |
| Jul 30, 2025 | Gaurav Aggarwal | Grant/Award | 21,200 | n/a |
| Jul 30, 2025 | Sandeep Laumas | Grant/Award | 21,200 | n/a |
| Jul 30, 2025 | Sara Kenkare-Mitra | Grant/Award | 21,200 | n/a |